IgG Therapy: Writing the Orders to Optimize the Outcome
Monday, March 6, 2017: 6:30 AM-7:30 AM
Hyatt Regency Atlanta, Atlanta Conference Level (LL3), Fairlie
1.00 CME/CE

Learning Objectives:
  1. Discuss and chose an IG product and routine of administration for their patient
  2. Identify an order for any IG product/administration modality
  3. Recognize and manage tolerability related to and serious adverse events caused by IG therapy
Discussion Leader
Alan P. Knutsen, MD FAAAAI
Discussion Leader
Richard L. Wasserman, MD PhD FAAAAI
  • AAAAI 2017 Session 4004.pdf (53.4 kB)
  • See more of: Session